financetom
Business
financetom
/
Business
/
Campbell's Snacking Earnings Likely to Weigh on Q3, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Campbell's Snacking Earnings Likely to Weigh on Q3, RBC Says
May 29, 2025 8:40 AM

11:22 AM EDT, 05/29/2025 (MT Newswires) -- Campbell's (CPB) weak snacking business will likely weigh on its fiscal Q3 results, RBC Capital Markets said in a Wednesday note.

"We are cautious on CPB going into F3Q earnings as packaged

food earnings have generally been soft, particularly in snacking," RBC analysts said. The results are due on June 2.

They also said that their channel work and scanner data currently do not support the firm's fiscal 2025 top-line guidance for organic growth to improve sequentially in H2.

"We think another cut may be inevitable given the negative data points," the analysts said. RBC has a sector perform rating and a $44 price target on the stock.

Price: 33.93, Change: +0.14, Percent Change: +0.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Calavo Growers Closes on $83 Million Sale of Fresh Cut Business
Calavo Growers Closes on $83 Million Sale of Fresh Cut Business
Aug 16, 2024
09:19 AM EDT, 08/16/2024 (MT Newswires) -- Calavo Growers ( CVGW ) said Friday that it has completed the $83 million sale of its Fresh Cut business and its related real estate to privately held F&S Fresh Foods. The deal closed on Thursday, the avocado and guacamole seller said. ...
Incyte Seeks Expanded FDA Approval For Lymphoma Drug After Releasing Promising Topline Data From Late-Stage Study
Incyte Seeks Expanded FDA Approval For Lymphoma Drug After Releasing Promising Topline Data From Late-Stage Study
Aug 16, 2024
On Friday, Incyte Corporation ( INCY ) released topline results from the pivotal Phase 3 inMIND trial evaluating the efficacy and safety of Monjuvi (tafasitamab) and lenalidomide as an add-on to rituximab compared with lenalidomide alone as an add-on to rituximab in patients with relapsed or refractory follicular lymphoma or relapsed or refractory nodal, splenic or extranodal marginal zone lymphoma (MZL)....
Cannara Biotech July National Market Share of 3.2% Is Highest Ever
Cannara Biotech July National Market Share of 3.2% Is Highest Ever
Aug 16, 2024
09:24 AM EDT, 08/16/2024 (MT Newswires) -- Cannara Biotech ( LOVFF ) , a cannabis producer, on Friday said it achieved a 3.2% national market share in July, the company's highest ever, which makes it the ninth largest licensed producer in Canada by that measure. We are thrilled to report that July 2024 marks a significant milestone for Cannara, with...
Carrier Global Sells Commercial And Residential Fire Business For $3B, Proceeds To Be Utilized For Stock Buybacks
Carrier Global Sells Commercial And Residential Fire Business For $3B, Proceeds To Be Utilized For Stock Buybacks
Aug 16, 2024
Carrier Global Corporation ( CARR ) disclosed on Thursday its plan to sell Commercial and Residential Fire business to an affiliate of Lone Star Funds for $3 billion. The sale of Carrier’s Commercial and Residential Fire business is a key step in its portfolio transformation following the January acquisition of Viessmann Climate Solutions and the divestiture of its Industrial Fire...
Copyright 2023-2026 - www.financetom.com All Rights Reserved